iCaReMe Global Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAstraZeneca
About this trial
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being 18 years or older
Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
Providing written informed consent to participate in the registry
Disqualifiers
Having a life-threatening co-morbidity with life expectancy below 1 year
Participating in an interventional trial requiring informed consent
Trial population
Adults with type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
1. Provide real world data on patient characteristics
Disease control (e.g. achievement of glycated hemoglobin target and incidence of hypoglycemic events) Management of micro- and/or macrovascular complications Management of associated risk factors (e.g. hypercholesterolemia and hypertension) Current diabetes, CKD and HF treatments Concomitant medications
Time frame
Average of 3 years through study completion2
2. Provide real world data on disease management
Disease control (e.g. achievement of glycated hemoglobin target and incidence of hypoglycemic events) Management of micro- and/or macrovascular complications Management of associated risk factors (e.g. hypercholesterolemia and hypertension) Current diabetes treatments Concomitant medications
Time frame
Average of 3 years through study completion3
3. Provide real world data on healthcare utilization
Number of diabetes, Chronic Kidney Disease(CKD) and Heart Failure(HF)-related visits to a physician not at study site Number of urgent care visits for diabetes Number of diabetes, CKD and HF-related hospital emergency department visits and reason(s) for visits Number of hospitalizations, lengths of stay, and reasons for hospitalizations
Time frame
Average of 3 years through study completion4
4. Provide real world data on quality of care indicators
Smoking cessation Eye and foot examinations Dietary counselling
Time frame
Average of 3 years through study completionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov